3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Carcinoma, Renal Cell
64
Carcinoma, Hepatocellular
26
Prostatic Neoplasms
22
Neoplasm Metastasis
19
Neoplasms
18
Carcinoma, Non-Small-Cell Lung
16
Kidney Neoplasms
14
Osteosarcoma
9
Neuroendocrine Tumors
9
Colorectal Neoplasms
9
Carcinoma, Transitional Cell
9
Sarcoma
8
Carcinoma, Medullary
8
Urinary Bladder Neoplasms
7
Sarcoma, Ewing
7
Melanoma
7
Breast Neoplasms
7
Brain Neoplasms
7
Thyroid Neoplasms
6
Ovarian Neoplasms
6
Clear-cell metastatic renal cell carcinoma
6
Recurrence
5
Pancreatic Neoplasms
5
Lung Neoplasms
5
Carcinoma
5
Urethral Neoplasms
4
Triple Negative Breast Neoplasms
4
Multiple Myeloma
4
Thyroid Cancer, Papillary
3
Small Cell Lung Carcinoma
3
Interventions
pembrolizumab
7
lenvatinib
3
apatinib
3
Magnetic Resonance Spectroscopy
3
Imatinib Mesylate
3
Carboplatin
3
gallium 68 PSMA-11
2
Specimen Handling
2
Protons
2
Nivolumab
2
Epirubicin
2
Cisplatin
2
Axitinib
2
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
2
3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione
2
tislelizumab
1
regorafenib
1
enfortumab vedotin
1
cabozantinib
1
avelumab
1
anlotinib
1
amivantamab
1
abemaciclib
1
Tretinoin
1
Trastuzumab
1
Tablets
1
Sunitinib
1
Standard of Care
1
Radiotherapy, Intensity-Modulated
1
Radiosurgery
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Carcinoma, Adenoid Cystic
×
cabozantinib
×
Clear all
NCT03729297
2021-03-12
Cabo ASAP
Radboud University Medical Center
Phase 2
Terminated
25 enrolled